Substance / Medication

Chlorpropamide

Overview

Active Ingredient
chlorpropamide
RxNorm CUI
2404

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

903 trials linked to this intervention

903
Total Trials
103
Recruiting
282
With Results

Research Evidence

Published studies and systematic reviews

Sort:
The polymorphic phase transformations in the chlorpropamide under pressure.
Kichanov Sergey E, Kozlenko Denis P, Wąsicki Jan et al. · J Pharm Sci · 2015
PMID: 25393056Observational
Crystallization and polymorphic transitions of chlorpropamide in aqueous 2-hydroxybutyl-beta-cyclodextrin solution.
Ishiguro Takako, Hirayama Fumitoshi, Iohara Daisuke et al. · Eur J Pharm Sci · 2010
PMID: 20036739Observational
Comparative bioavailability study with two chlorpropamide tablet formulations in healthy volunteers.
da Silva Marcia Aparecida, Mendes Fabiana D, de Oliveira Rogério Antonio et al. · Arzneimittelforschung · 2007
PMID: 17966758Observational
Demonstration of a shear-based solid-state phase transformation in a small molecular organic system: chlorpropamide.
Wildfong Peter L D, Morris Kenneth R, Anderson Carl A et al. · J Pharm Sci · 2007
PMID: 17455336Observational
Catching new modulated high-pressure phases of δ-chlorpropamide: when the experimental setup matters.
Bogdanov Nikita E, Rashchenko Sergey V, Zakharov Boris A et al. · IUCrJ · 2026
PMID: 41557337Other
Solid solution polymorphs afford two highly soluble co-drug forms of tolbutamide and chlorpropamide.
Spoletti Enrico, Verma Vivek, Cappuccino Chiara et al. · Chem Commun (Camb) · 2023
PMID: 37971413Other
Synthon Approach in Crystal Engineering to Modulate Physicochemical Properties in Organic Salts of Chlorpropamide.
Menon Anila M, Sidhartha Nagamalli Naga, Shruti Ipsha et al. · Mol Pharm · 2024
PMID: 38688017Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Chlorpropamide (substance)
SNOMED CT
386991003
UMLS CUI
C0008287
RxNorm CUI
2404

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

1
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
903
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Chlorpropamide — Conditions, Biomarkers & Specialists | Healos | Healos